Evidence map›Paper›PMID 33810548›Full record

ReviewGenes2021

Novel

Katarina Trebusak Podkrajsek, Tine Tesovnik, Nina Bozanic Urbancic, Saba Battelino

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Katarina Trebusak PodkrajsekInstitute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.ORCID 0000-0002-0154-3547
Tine TesovnikUniversity Medical Centre Ljubljana, University Children's Hospital, Bohoriceva 20, 1000 Ljubljana, Slovenia.
Nina Bozanic UrbancicDepartment of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia.
Saba BattelinoDepartment of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia.ORCID 0000-0003-1478-0573
Ljubljana University Medical Centre · SIUniversity of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In contrast to the recessive form, hearing loss inherited in a dominant manner is more often post-lingual and typically results in a progressive sensorineural hearing loss with variable severity and late onset. Variants in the

Indexed as

Polymorphism, Single NucleotideAdultAge of OnsetAmino Acid SubstitutionDNA-Binding ProteinsFemaleHearing LossHigh-Throughput Nucleotide SequencingHumansMiddle AgedPedigreeSequence Analysis, DNATranscription FactorsDNA-Binding ProteinsGRHL2 protein, humanTranscription Factorsautosomal-dominant hearing lossGRHL2next-generation sequencingNGS

Identifiers

PMID33810548
PMCPMC8066333
OpenAlexW3141357909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.